Despite significance being reached only on the extra-tumor immune component, a reduction of CD4 (p = 0.0066), CD8 (p = 0.0061), and PD-1 (p = 0.0196) signals on stromal cells of patients with high inflammatory profile was also observed (Figure 1). The gene discussed is PDCD1; the disease is neoplasm.